Literature DB >> 17475689

The use of serological titres of IgA and IgG in (early) discrimination between rectal infection with non-lymphogranuloma venereum and lymphogranuloma venereum serovars of Chlamydia trachomatis.

Eric M van der Snoek1, Jacobus M Ossewaarde, Willem I van der Meijden, Paul G H Mulder, H Bing Thio.   

Abstract

OBJECTIVES: To investigate whether serological titres of species-specific IgA and IgG antibodies in patients with rectal chlamydial infection could discriminate between infection with serovar L2 lymphogranuloma venereum (LGV) and infection with non-LGV serovars.
METHODS: A total of 39 male patients with chlamydial infection of the rectum were tested for titres of IgA and IgG antibodies within 14 days after detection of the infection and 6 and 12 months after adequate treatment. Data were collected regarding demographics, sexual orientation, HIV serostatus, history of chlamydial infection, concomitant sexually transmitted infection (STI) or HIV infection, hepatitis C virus antibodies and new STIs during follow-up.
RESULTS: Between May 2003 and November 2005, 24 men with confirmed L2 proctitis and 15 men with non-LGV rectal chlamydial infection were recruited. In multivariable analyses, both high titre of IgA within 14 days after detection of the infection and older age of the individual were found significantly associated with L2 proctitis (p<0.001 and p = 0.001, respectively). A total sum score of seven times IgA titre and individual's age >or=50 years resulted in an overall sensitivity of 92% and specificity of 100%. This total sum score was highly accurate for detection of LGV proctitis, with an area under the curve in a receiver operating characteristic curve of 0.989.
CONCLUSIONS: An increased IgA antibody response and the age of the infected individual are of possible diagnostic value for (early) detection of LGV proctitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475689      PMCID: PMC2598666          DOI: 10.1136/sti.2006.024372

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  16 in total

Review 1.  Immunologic uniqueness of the genital tract: challenge for vaccine development.

Authors:  Jiri Mestecky; Zina Moldoveanu; Michael W Russell
Journal:  Am J Reprod Immunol       Date:  2005-05       Impact factor: 3.886

2.  Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis.

Authors:  S A Morré; J M Ossewaarde; J Lan; G J van Doornum; J M Walboomers; D M MacLaren; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars.

Authors:  J M Ossewaarde; M Rieffe; A de Vries; R P Derksen-Nawrocki; H J Hooft; G J van Doornum; A M van Loon
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

4.  Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands.

Authors:  J van Bergen; H M Götz; J H Richardus; C J P A Hoebe; J Broer; A J T Coenen
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

5.  Prevalence of STD and HIV infections among attenders of the Erasmus MC STD clinic, Rotterdam, The Netherlands, during the years 1996 to 2000.

Authors:  E M van der Snoek; H M Götz; P G H Mulder; R P Verkooyen; W I van der Meijden
Journal:  Int J STD AIDS       Date:  2003-02       Impact factor: 1.359

6.  Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis.

Authors:  Sophie Dessus-Babus; Toni L Darville; Francis P Cuozzo; Kaethe Ferguson; Priscilla B Wyrick
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  Cytoskeletal requirements in Chlamydia trachomatis infection of host cells.

Authors:  N Schramm; P B Wyrick
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men.

Authors:  Rutger F Nieuwenhuis; Jacobus M Ossewaarde; Hannelore M Götz; Jan Dees; H Bing Thio; Maarten G J Thomeer; Jan C den Hollander; Martino H A Neumann; Willem I van der Meijden
Journal:  Clin Infect Dis       Date:  2004-09-08       Impact factor: 9.079

9.  Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials.

Authors:  Chuen-Yen Lau; Azhar K Qureshi
Journal:  Sex Transm Dis       Date:  2002-09       Impact factor: 2.830

10.  Confirmatory serodiagnosis of lymphogranuloma venereum proctitis may yield false-positive results due to other chlamydial infections of the rectum.

Authors:  J Schachter
Journal:  Sex Transm Dis       Date:  1981 Jan-Mar       Impact factor: 2.830

View more
  5 in total

1.  Focus on Chlamydia.

Authors:  Nicola Low; Helen Ward
Journal:  Sex Transm Infect       Date:  2007-07       Impact factor: 3.519

2.  Surveillance of sexually transmitted infections among persons living with HIV.

Authors:  Ann Defraye; Dominique Van Beckhoven; André Sasse
Journal:  Int J Public Health       Date:  2010-12-03       Impact factor: 3.380

Review 3.  Advances in sexually transmitted infections of the gastrointestinal tract.

Authors:  Siew C Ng; Brian Gazzard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-25       Impact factor: 46.802

4.  The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis.

Authors:  Minttu M Rönn; Helen Ward
Journal:  BMC Infect Dis       Date:  2011-03-18       Impact factor: 3.090

5.  Chlamydia trachomatis Antibody Testing in Vaginal Mucosal Material versus Blood Samples of Women Attending a Fertility Clinic and an STI Clinic.

Authors:  Ingrid V F van den Broek; Jolande A Land; Jan E A M van Bergen; Servaas A Morré; Marianne A B van der Sande
Journal:  Obstet Gynecol Int       Date:  2014-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.